181 related articles for article (PubMed ID: 25824289)
1. Clinical efficacy of autologous stem cell transplantation for the treatment of patients with type 2 diabetes mellitus: a meta-analysis.
Wang ZX; Cao JX; Li D; Zhang XY; Liu JL; Li JL; Wang M; Liu Y; Xu BL; Wang HB
Cytotherapy; 2015 Jul; 17(7):956-68. PubMed ID: 25824289
[TBL] [Abstract][Full Text] [Related]
2. Autologous bone marrow mononuclear cell infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: an open-label, randomized controlled clinical trial.
Wu Z; Cai J; Chen J; Huang L; Wu W; Luo F; Wu C; Liao L; Tan J
Cytotherapy; 2014 Feb; 16(2):258-65. PubMed ID: 24290656
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.
Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM
Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760
[TBL] [Abstract][Full Text] [Related]
4. Autologous intraarterial pancreatic bone-marrow mononuclear cells infusion in T2D patients: Changes on beta-cells function, insulin resistance, and inflammatory marker.
Kurniawan F; Subekti I; Yunir E; Harbuwono DS; Purnamasari D; Tarigan TJE; Wisnu W; Tahapary DL; Wafa S; Astrella C; Christabel EV; Lubis AM; Wijaya IP; Karim B; Azizi MS; Suroyo I; Matondang S; Wicaksono KP; Wulandari D; Fasha I; Sartika CR; Irawan C; Soewondo P
Curr Res Transl Med; 2024 Jun; 72(2):103437. PubMed ID: 38244275
[TBL] [Abstract][Full Text] [Related]
5. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.
Thakkar UG; Trivedi HL; Vanikar AV; Dave SD
Cytotherapy; 2015 Jul; 17(7):940-7. PubMed ID: 25869301
[TBL] [Abstract][Full Text] [Related]
6. Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia.
Smadja DM; Duong-van-Huyen JP; Dal Cortivo L; Blanchard A; Bruneval P; Emmerich J; Gaussem P
Cytotherapy; 2012 Feb; 14(2):232-9. PubMed ID: 22040109
[TBL] [Abstract][Full Text] [Related]
7. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
[TBL] [Abstract][Full Text] [Related]
8. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
[TBL] [Abstract][Full Text] [Related]
9. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium.
Kamihata H; Matsubara H; Nishiue T; Fujiyama S; Amano K; Iba O; Imada T; Iwasaka T
Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1804-10. PubMed ID: 12426208
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study.
Bhansali S; Dutta P; Kumar V; Yadav MK; Jain A; Mudaliar S; Bhansali S; Sharma RR; Jha V; Marwaha N; Khandelwal N; Srinivasan A; Sachdeva N; Hawkins M; Bhansali A
Stem Cells Dev; 2017 Apr; 26(7):471-481. PubMed ID: 28006991
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA after autologous bone marrow mononuclear cell (BM-MNC) injection in patients with ischemic stroke.
Mancha F; Escudero-Martinez I; Zapata-Arriaza E; Vega-Salvatierra A; Cabezas JA; Lebrato L; Pardo B; De-La-Torre J; Zapata M; Escamilla V; Calderón-Cabrera C; Martín-Sánchez J; Valverde R; Aguera-Morales E; Herrera I; Delgado F; Gamero MÁ; Pérez-Sánchez S; Moya M; Espinosa R; Ortega-Quintanilla J; Gutierrez-Jarrin I; González-García A; Montaner J; Moniche F
J Investig Med; 2020 Mar; 68(3):807-810. PubMed ID: 31852749
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow stem cell transplantation for the treatment of type 2 diabetes mellitus.
Wang L; Zhao S; Mao H; Zhou L; Wang ZJ; Wang HX
Chin Med J (Engl); 2011 Nov; 124(22):3622-8. PubMed ID: 22340214
[TBL] [Abstract][Full Text] [Related]
14. Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product.
Capiod JC; Tournois C; Vitry F; Sevestre MA; Daliphard S; Reix T; Nguyen P; Lefrère JJ; Pignon B
Vox Sang; 2009 Apr; 96(3):256-65. PubMed ID: 19207166
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.
Zafarghandi MR; Ravari H; Aghdami N; Namiri M; Moazzami K; Taghiabadi E; Fazel A; Pournasr B; Farrokhi A; Sharifian RA; Salimi J; Moini M; Baharvand H
Cytotherapy; 2010 Oct; 12(6):783-91. PubMed ID: 20078390
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
[TBL] [Abstract][Full Text] [Related]
17. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation.
Hernández P; Cortina L; Artaza H; Pol N; Lam RM; Dorticós E; Macías C; Hernández C; del Valle L; Blanco A; Martínez A; Díaz F
Atherosclerosis; 2007 Oct; 194(2):e52-6. PubMed ID: 16982058
[TBL] [Abstract][Full Text] [Related]
18. [A FOLLOW-UP STUDY ON AUTOLOGOUS BONE MARROW MONONUCLEAR CELLS TRANSPLANTATION FOR CRITICAL LOWER ARTERIOSCLEROSIS OBLITERANS IN DIABETIC PATIENTS].
Dou Y; Zhao J; Zhang L; Wang X; Yuan H; Yuan C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Jul; 29(7):893-8. PubMed ID: 26540987
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus: a randomized placebo-controlled study.
Bhansali A; Asokumar P; Walia R; Bhansali S; Gupta V; Jain A; Sachdeva N; Sharma RR; Marwaha N; Khandelwal N
Cell Transplant; 2014; 23(9):1075-85. PubMed ID: 23561959
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests.
Rinaldi C; Savignano C; Silvestri F; Geromin A; Cerno M; Fanin R; Biffoni F; Baccarani M
Haematologica; 1995; 80(5):443-7. PubMed ID: 8566888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
